학술논문
Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma
Document Type
Article
Author
Kubicki, Tadeusz; Dytfeld, Dominik; Barnidge, David; Sakrikar, Dhananjay; Przybyłowicz-Chalecka, Anna; Jamroziak, Krzysztof; Robak, Paweł; Czyż, Jarosław; Tyczyńska, Agata; Druzd-Sitek, Agnieszka; Giannopoulos, Krzysztof; Wróbel, Tomasz; Nowicki, Adam; Szczepaniak, Tomasz; Łojko-Dankowska, Anna; Matuszak, Magdalena; Gil, Lidia; Puła, Bartosz; Szukalski, Łukasz; Końska, Agnieszka; Zaucha, Jan Maciej; Walewski, Jan; Mikulski, Damian; Czabak, Olga; Robak, Tadeusz; Jiang, Ken; Cooperrider, Jennifer H.; Jakubowiak, Andrzej J.; Derman, Benjamin A.
Source
Blood; 20240101, Issue: Preprints
Subject
Language
ISSN
00064971; 15280020
Abstract
•MS provides significant prognostic information in the maintenance setting and complements BM MRD in multiple myeloma.•Without the aid of a baseline serum sample, MS’s prognostic performance is most significant 18 months after transplant.